期刊
ISCIENCE
卷 25, 期 1, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.isci.2021.103679
关键词
-
资金
- National Cancer Institute [CA143193]
- Uniformed Services University of the Health Sciences (USUHS) [RAMP310534]
Abnormal activation of SETBP1 is frequently found in myeloid neoplasms and is associated with poor prognosis. The direct interaction between SETBP1 and histone methyltransferase MLL1 plays a critical role in SETBP1-induced transcriptional activation and transformation, and represents a promising target for treating myeloid neoplasms with SETBP1 activation.
Abnormal activation of SETBP1 due to overexpression or missense mutations occurs frequently in various myeloid neoplasms and associates with poor prognosis. Direct activation of Hoxa9/Hoxa10/Myb transcription by SETBP1 and its missense mutants is essential for their transforming capability; however, the underlying epigenetic mechanisms remain elusive. We found that both SETBP1 and its missense mutant SETBP1(D/N) directly interact with histone methyltransferase MLL1. Using a combination of ChIP-seq and RNA-seq analysis in primary hematopoietic stem and progenitor cells, we uncovered extensive overlap in their genomic occupancy and their cooperation in activating many oncogenic transcription factor genes including Hoxa9/Hoxa10/Myb and a large group of ribosomal protein genes. Genetic ablation of Mll1 as well as treatment with an inhibitor of the MLL1 complex OICR-9429 abrogated Setbp1/Setbp1(D/N)- induced transcriptional activation and transformation. Thus, the MLL1 complex plays a critical role in Setbp1-induced transcriptional activation and transformation and represents a promising target for treating myeloid neoplasms with SETBP1 activation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据